Chemotherapy dose-intensification for pediatric patients with Ewing's family of tumors and desmoplastic small round-cell tumors: A feasibility study at St. Jude children's research hospital

Journal of Clinical Oncology

Volumn 17, Issue 1, 1999, Pages 180-190

  Marina, Neyssa M ^a   Pappo, Alberto S ^a   Parham, David M ^a   Cain, Alvida M ^a   Rao, Bhaskar N ^a   Poquette, Catherine A ^a   Pratt, Charles B ^a   Greenwald, Carol ^a   Meyer, William H ^a  

^a UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOPHOSPHAMIDE; DACTINOMYCIN; DOXORUBICIN; ETOPOSIDE; GRANULOCYTE COLONY STIMULATING FACTOR; IFOSFAMIDE; VINCRISTINE;

ADOLESCENT; ADULT; ARTICLE; BONE SCINTISCANNING; CANCER CHEMOTHERAPY; CANCER SURVIVAL; CHILD; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DESMOPLASTIC SMALL ROUND CELL TUMOR; ESOPHAGITIS; EWING SARCOMA; FEBRILE NEUTROPENIA; FEMALE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; LUNG FIBROSIS; MAJOR CLINICAL STUDY; MALE; NEUTROPENIA; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PROGNOSIS; RADIATION DOSE; RADIATION PNEUMONIA; RANDOMIZED CONTROLLED TRIAL; THROMBOCYTOPENIA; TREATMENT OUTCOME;

EID: 0032920240     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/jco.1999.17.1.180     Document Type: Article

References (50)

1. Dahlin DC, Coventry MB, Scanlon P: Ewing's sarcoma. J Bone Joint Surg 43A:185-192, 1961
2. Bhansali SK, Desai PB: Ewing's sarcoma: Observation on 107 cases. J Bone Joint Surg 45A:541-553, 1963
3. Falk S, Alpert M: Five-year survival of patients with Ewing's sarcoma. Surg Gynecol Obstet 124:319-324, 1967
4. Phelan JT, Cabrera A: Ewing's sarcoma. Surg Gynecol Obstet 118:795-800, 1964
5. Freeman AI, Sachatello C, Gaeta J, et al: An analysis of Ewing's tumor in children at Roswell Park Memorial Institute. Cancer 29:1563-1569, 1972
6. Jurgens H, Exner U, Gadner H, et al: Multidisciplinary treatment of primary Ewing's sarcoma of bone: A 6-year experience of a European cooperative trial. Cancer 61:23-32, 1988
7. Bacci G, Toni A, Avella M, et al: Long-term results in 144 localized Ewing's sarcoma patients treated with combined therapy. Cancer 63:1477-1486, 1989
8. Barbieri E, Emiliani E, Zini G, et al: Combined therapy of localized Ewing's sarcoma of bone: Analysis of results in 100 patients. Int J Radiat Oncol Biol Phys 19:1165-1170, 1990
9. Kinsella TJ, Miser JS, Waller B, et al: Long-term follow-up of Ewing's sarcoma of bone treated with combined modality therapy. Int J Radiat Biol Phys 20:389-395, 1991
10. Haggard ME: Cyclophosphamide (NSC-26271) in the treatment of children with malignant neoplasms. Cancer Chemother Rep 51:403-405, 1967
11. Samuels ML, Howe CD: Cyclophosphamide in the management of Ewing's sarcoma. Cancer 20:961-966, 1967
12. Johnson R, Humphreys SR: Past failures and future possibilities in Ewing's sarcoma: Experimental and preliminary clinical results. Cancer 23:161-166, 1969
13. Oldham RK, Pomeroy TC: Treatment of Ewing's sarcoma with Adriamycin (NSC 123127). Cancer Chemother Rep 56:635-639, 1972
14. Miser JS, Kinsella TJ, Triche TJ, et al: Ifosfamide with mesna uroprotection and etoposide: An effective regimen in the treatment of recurrent sarcomas and other tumors of children and young adults. J Clin Oncol 5:1191-1198, 1987
15. Grier H, Krailo M, Link M, et al: Improved outcome in non-metastatic Ewing's sarcoma (EWS) and PNET of bone with the addition of ifosfamide (I) and etoposide (E) to vincristine (V), Adriamycin (A), cyclophosphamide (C), and actinomycin (A): A Children's Cancer Group (CCG) and Pediatric Oncology Group (POG) report. Proc Am Soc Clin Oncol 13:421, 1994 (abstr)
16. Mierau GW: Extraskeletal Ewing's sarcoma (peripheral neuroepithelioma). Ultrastruct Pathol 9:91-98, 1985
17. Haas OA, Chott A, Ladenstein R, et al: Poorly differentiated, neuron-specific enolase positive round-cell tumor with two translocations t(11;22) and t(21;22). Cancer 60:2219-2223, 1987
18. Turc-Carel C, Philip T, Berger MP, et al: Chromosome study of Ewing's sarcoma (ES) cell lines: Consistency of reciprocal translocation t(11;22)(q24:q12). Cancer Genet Cytogenet 12:1-19, 1984
19. Gerald WL, Miller HK, Battifora H, et al: Intra-abdominal desmoplastic small round-cell tumor: Report of 19 cases of a distinctive type of high-grade polyphenotypic malignancy affecting young individuals. Am J Surg Pathol 15:499-513, 1991
20. Argatoff LH, O'Connel JX, Mathers JA, et al: Detection of the EWS/WT1 gene fusion by reverse transcriptase-polymerase chain reaction in the diagnosis of intra-abdominal desmoplastic small round-cell tumor. Am J Surg Pathol 20:406-412, 1996
21. De Alava E, Ladany M, Rosai J, et al: Detection of chimeric transcripts in desmoplastic small round-cell tumor and related developmental tumors by reverse transcriptase polymerase chain reaction: A specific diagnostic assay. Am J Pathol 147:1584-1591, 1995
22. Kushner BH, LaQuaglia MP, Wollner N, et al: Desmoplastic small round-cell tumor: Prolonged progression-free survival with aggressive multimodality therapy. J Clin Oncol 14:1526-1531, 1996
23. Hryniuk W, Bush H: The importance of dose intensity in chemotherapy of metastatic breast cancer. J Clin Oncol 2:1281-1288, 1984
24. Levin L, Hryniuk WM: Dose intensity analysis of chemotherapy regimens in ovarian carcinoma. J Clin Oncol 5:756-767, 1987
25. Cheung V, Heller G: Chemotherapy dose intensity correlates strongly with response, median survival, and median progression-free survival in metastatic neuroblastoma. J Clin Oncol 9:1050-1058, 1991
26. Kushner B, Meyers P, Gerald W, et al: Very-high-dose short-term chemotherapy for poor-risk peripheral primitive neuroectodermal tumors, including Ewing's sarcoma, in children and young adults. J Clin Oncol 13:2796-2804, 1995
27. Arai Y, Kun LE, Brooks T, et al: Ewing's sarcoma: Local disease control and patterns of failure following limited volume radiation therapy. Int J Radiat Oncol 21:1501-1508, 1991
28. Meyer WH, Kun LE, Marina N, et al: Ifosfamide plus etoposide in newly diagnosed Ewing's sarcoma of bone. J Clin Oncol 10:1737-1742, 1992
29. Sandoval C, Meyer WH, Parham DM, et al: Outcome in 43 children presenting with metastatic Ewing's sarcoma: The St. Jude Children's Research Hospital experience, 1962 to 1992. Med Pediatr Oncol 26:180-185, 1996
30. Nesbit ME Jr, Gehan EA, Burgen O Jr, et al: Multimodal therapy for the management of primary nonmetastatic Ewing's sarcoma of bone: A long-term follow-up of the First Intergroup Study. J Clin Oncol 8:1-11, 1990
31. Burgert EO Jr, Nesbit ME, Garnsey LA, et al: Multimodal therapy for the management of nonpelvic localized Ewing's sarcoma of bone: Intergroup Study IESS II. J Clin Oncol 8:1514-1524, 1990
32. Santana VM, Bowman L, Furman W, et al: A phase I-II trial of human granulocyte colony-stimulating factor (rG-CSF) in children with disseminated neuroblastoma (DNb). Proc Am Soc Clin Oncol 13:426, 1994 (abstr)
33. Morstyn G, Campbell L, Lieschke G, et al: Treatment of chemotherapy-induced neutropenia by subcutaneously administered granulocyte colony-stimulating factor with optimization of dose and duration of therapy. J Clin Oncol 7:1554-1562, 1989
34. Zelen M: The analysis of several 2 × 2 contingency tables. Biometrika 44:1049-1060, 1971
35. Kaplan EL, Meier P: Nonparametric estimation from incomplete observations. J Am Stat Assoc 53:457-481, 1958
36. Peto R, Pike MC, Armitage P, et al: Design and analysis of randomized clinical trials requiring prolonged observation of each patients: II. Analysis and examples. Br J Cancer 35:1-39, 1977
37. Kalbfleisch JD, Prentice RL: The Statistical Analysis of Failure Time Data. New York, NY, John Wiley & Sons, 1980
38. Gray RJ: A class of K-sample tests for comparing the cumulative incidence of a competing risk. Ann Stat 16:1141-1154, 1988
39. Kosary CL, Ries LAG, Miller BA, et al: SEER Cancer Statistics Review, 1973-1992: Tables and Graphs, National Cancer Institute. Bethesda, MD, NIH publication 96-2789, 1995
40. Breslow NE, Day NE: Statistical Methods in Cancer Research Volume II: The Design and Analyses of Cohort Studies. Lyon, France, International Agency for Research on Cancer, 1987
41. Crawford J, Ozer H, Stoller R, et al: Reduction by granulocyte colony-stimulating factor of fever and neutropenia induced by chemotherapy in patients with small-cell lung cancer. N Engl J Med 325:164-170, 1991
42. Burdach SEG, Muschenich M, Josephs W, et al: Granulocyte-macrophage-colony stimulating factor for prevention of neutropenia and infections in children and adolescents with solid tumors. Cancer 76:510-516, 1995
43. Antman KS, Griffin JD, Elias A, et al: Effect of recombinant human granulocyte-macrophage colony-stimulating factor on chemotherapy-induced myelosuppression. N Engl J Med 319:593-598, 1988
44. Ohno R, Tomonaga M, Kobayashi T, et al: Effect of granulocyte colony-stimulating factor after intensive induction therapy in relapsed or refractory acute leukemia. N Engl J Med 323:871-877, 1990
45. Neidhart JA, Mangalik A, Stidley CA, et al: Dosing regimen of granulocyte-macrophage colony-stimulating factor to support dose-intensive chemotherapy. J Clin Oncol 10:1460-1469, 1992
46. Ruymann FB, Vietti T, Gehan E, et al: Cyclophosphamide dose escalation in combination with vincristine and Actinomycin-D (VAC) in gross residual sarcoma: A pilot study without hematopoietic growth factor support evaluating toxicity and response. J Pediatr Hematol Oncol 17:331-337, 1995
47. Kuttesch JF, Wexler LH, Marcus RB, et al: Second malignancies after Ewing's sarcoma: Radiation dose-dependency of secondary sarcomas. J Clin Oncol 14:2818-2825, 1996
48. Miser J, Krailo M, Smith M, et al: Secondary leukemia (SL) or myelodysplastic syndrome (MDS) following therapy for Ewing's sarcoma (ES). Proc Am Soc Clin Oncol 16:518a, 1997 (abstr)
49. Schmidt D, Herrmann C, Jurgens H, et al: Malignant peripheral neuroectodermal tumor and its necessary distinction from Ewing's sarcoma. A report from the Kiel Pediatric Tumor Registry. Cancer 68:2251-2259, 1991
50. Hijazi Y, Worthy E, Steinberg S, et al: Ewing's sarcoma (ES) vs. primitive neuroectodermal tumor (PNET): Does histology play a role in prognosis. Mod Pathol 6:126A, 1993